Jun 16, 2026 10:18AM
Jun 16, 2026 07:00AM
Jun 16, 2026 07:00AM
Jun 1, 2026 08:31AM
Jun 1, 2026 08:30AM
May 7, 2026 08:00AM
Mar 10, 2026 07:02AM Edgewise reports sevasemten stabilized function in Becker dystrophy study
Mar 10, 2026 07:00AM
Mar 3, 2026 08:00AM
Feb 26, 2026 08:00AM
Jan 13, 2026 08:00AM
Dec 24, 2025 08:00AM
Dec 24, 2025 08:00AM
Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note
Nov 20, 2025 08:00AM
Nov 20, 2025 08:00AM
Nov 10, 2025 08:01AM
Nov 10, 2025 08:00AM
Nov 6, 2025 08:00AM
Oct 2, 2025 08:00AM
Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
Aug 8, 2025 08:43AM
Aug 7, 2025 10:44AM
Aug 7, 2025 08:00AM
Jul 3, 2025 10:00AM
Jul 1, 2025 10:00AM
Jun 28, 2025 10:00AM
Jun 26, 2025 10:32AM Stifel Reiterates Hold Rating on Edgewise Therapeutics (EWTX)
Jun 26, 2025 06:00AM
Jun 26, 2025 06:00AM
Jun 11, 2025 08:35AM
Jun 5, 2025 08:53AM
May 8, 2025 08:00AM
Mar 11, 2025 08:00AM
Mar 10, 2025 09:44AM Piper Sandler: 'We Remain Bullish on Edgewise Therapeutics (EWTX) and See Compelling Buying Opportunity'
Mar 3, 2025 08:00AM
Jan 13, 2025 12:50PM
Jan 13, 2025 08:00AM
Jan 2, 2025 12:51PM
Dec 16, 2024 06:05AM
Dec 16, 2024 06:00AM
Dec 5, 2024 02:32PM Edgewise Therapeutics Inc. (EWTX) Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research
Dec 5, 2024 02:32PM
Dec 5, 2024 01:02PM
May 9, 2024 08:00AM
Apr 23, 2024 08:02AM
Apr 23, 2024 08:00AM
Apr 15, 2024 04:06PM
Apr 15, 2024 04:05PM Edgewise Therapeutics Announces Positive Two-Year Topline Results from the ARCH Open Label Trial of Sevasemten (EDG-5506) in Adults with Becker Muscular Dystrophy (Becker)
Feb 22, 2024 08:00AM

323,293 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All